• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AIZU OLYMPUS CO., LTD. EVIS EXERA III GASTROINTESTINAL VIDEOSCOPE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AIZU OLYMPUS CO., LTD. EVIS EXERA III GASTROINTESTINAL VIDEOSCOPE Back to Search Results
Model Number GIF-HQ190
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hemorrhage/Bleeding (1888); Perforation (2001)
Event Date 11/12/2021
Event Type  Injury  
Manufacturer Narrative
The suspect device has not been returned to olympus for evaluation.The investigation is in process.The literature article is attached for additional information.Once the investigation has been completed, a supplemental report will be submitted with device evaluation results.
 
Event Description
Olympus reviewed the following literature titled "efficacy and safety of endoscopic submucosal dissection for superficial gastric neoplasms: a latin american cohort study" background/aims: endoscopic submucosal dissection (esd) is the preferred technique for treating early gastric cancer (egc).However, very few studies have been conducted in south america.This study aimed to assess the efficacy and safety of esd for egc.Methods: we analyzed data from a prospective cohort from 2013 to 2020.A total of 152 superficial gastric neoplasms that fulfilled the absolute or expanded criteria for esd were included.Outcomes were en bloc, r0, and curative resection rates, incidence of adverse events, and length of procedure.Results: the age of the enrolled patients was 68.4±11.3 years.The number of included patients based on the absolute and expanded indications was 150 and 2, respectively.En bloc, r0, and curative resections were achieved in 98.0%, 96.1%, and 89.5% of the cases, respectively.Bleeding and perforation were reported in 5.9% and 6.6% of the cases, respectively.Histopathological examination revealed low-grade dysplasia, high-grade dysplasia, well-differentiated adenocarcinoma, and poorly differentiated adenocarcinoma in 13, 20, 117, and 2 cases, respectively.Conclusions: our study shows that esd performed by properly trained endoscopists in reference centers is safe and effective, with comparable therapeutic outcomes to those reported in the eastern series.Type of adverse events/number of patients: immediate perforation - 9 patients.Delayed perforation - 1 patient.Intraprocedural bleeding - 3 patients.Delayed bleeding - 6 patients.This literature article requires 4 reports.The related patient identifiers are as follows: (b)(6).This medwatch report is for patient identifier (b)(6).There is no report of any olympus device malfunction in any procedure described in this study.
 
Manufacturer Narrative
This report is being supplemented to provide additional literature article inadvertently omitted from the initial medwatch report.
 
Manufacturer Narrative
This report is being supplemented to provide additional information based on the legal manufacturer's final investigation.The device history record was unable to be reviewed for this device since the serial and/or lot number was not provided.However, olympus only releases products to market that meet all manufacturing specifications and final product release criteria.Based on the results of the investigation, the relationship between the device and the adverse event cannot be confirmed.There was no complaint reported on the subject device.There is no evidence of an olympus device malfunction.Therefore, the root cause cannot be determined.This supplemental report includes a correction to e4 to provide information that was inadvertently not included on the initial medwatch.Olympus will continue to monitor field performance for this device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVIS EXERA III GASTROINTESTINAL VIDEOSCOPE
Type of Device
GASTROINTESTINAL VIDEOSCOPE
Manufacturer (Section D)
AIZU OLYMPUS CO., LTD.
3-1-1 niiderakita
aizuwakamatsu-shi, fukushima 965-8 520
JA  965-8520
Manufacturer (Section G)
AIZU OLYMPUS CO., LTD.
3-1-1 niiderakita
aizuwakamatsu-shi, fukushima
Manufacturer Contact
todd brill
800 west park drive
westborough, MA 01581
5082077661
MDR Report Key16292645
MDR Text Key308734203
Report Number9610595-2023-01732
Device Sequence Number1
Product Code FDS
UDI-Device Identifier04953170305276
UDI-Public04953170305276
Combination Product (y/n)N
Reporter Country CodePE
PMA/PMN Number
K131780
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Study,Literature,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 04/17/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberGIF-HQ190
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 02/03/2023
Initial Date FDA Received02/03/2023
Supplement Dates Manufacturer Received02/03/2023
04/05/2023
Supplement Dates FDA Received02/03/2023
04/17/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-